Page 1 of Clinical Trials for ( Drug docetaxel AND cisplatin ), 288 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC)
Last Updated: March 29, 2011
Condition(s): Nasopharyngeal Carcinoma
2
Active, not recruiting
Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer (Paradigm Trial)
Last Updated: July 1, 2009
Condition(s): Head and Neck Cancer
3
Completed
Docetaxel (Taxotere), Vinorelbine, and Bevacizumab, as Adjuvant Chemotherapy for Patients With Resected Stage I-III Non-small Cell Lung Cancer
Last Updated: February 8, 2012
Condition(s): Lung Cancer
4
Completed
Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Last Updated: April 6, 2011
Condition(s): Anemia; Drug/Agent Toxicity by Tissue/Organ; Lung Cancer; Neutropenia
5
Active, not recruiting
Docetaxel, Cisplatin, and Amifostine in Treating Patients With Advanced Non-Small Cell Lung Cancer
Last Updated: May 9, 2009
Condition(s): Drug/Agent Toxicity by Tissue/Organ; Lung Cancer
6
Recruiting
Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
Last Updated: January 17, 2012
Condition(s): Gastroesophageal Junction Adenocarcinoma; Gastric Cancer
7
Completed
Taxotere, Cisplatin, and CPT-11 in Advanced Solid Tumor Malignancies
Last Updated: April 24, 2009
Condition(s): Solid Tumor
8
Recruiting
Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin
Last Updated: January 6, 2011
Condition(s): Non-small Cell Lung Cancer
9
Recruiting
Biweekly Schedule of Docetaxel and Cisplatin in Patients With Unresectable Non-small Cell Lung Cancer (NSCLC)
Last Updated: December 9, 2009
Condition(s): Non-small Cell Lung Cancer
10
Not yet recruiting
Phase I/II Study of Weekly Docetaxel and Cisplatin Together With Capecitabine and Bevacizumab in Advanced Gastric Cancer
Last Updated: February 16, 2009
Condition(s): Advanced Gastric Cancer
11
Active, not recruiting
Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer
Last Updated: July 23, 2008
Condition(s): Pancreatic Cancer
12
Not yet recruiting
A Chinese Randomized Crossover Study of Erlotinib Versus Docetaxel/Cisplatin in Previously Untreated Stage IIIB/IV Lung Adenocarcinoma With EGFR Mutations
Last Updated: May 26, 2010
Condition(s): Neoplasms, Lung; Carcinoma, Non-Small Cell Lung; Drug Therapy; Genes, EGFR
13
Completed
Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the Pancreas
Last Updated: June 21, 2011
Condition(s): Pancreatic Cancer
14
Completed
S0216, Combination Chemotherapy and RT in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Last Updated: July 21, 2011
Condition(s): Head and Neck Cancer
15
Terminated
Docetaxel and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Last Updated: May 9, 2011
Condition(s): Lung Cancer
16
Completed
Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Docetaxel and Cisplatin in Patients With Solid Tumors
Last Updated: December 15, 2011
Condition(s): Neoplasms, Malignant
17
Completed
Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal Adenocarcinoma
Last Updated: January 17, 2012
Condition(s): Stomach Neoplasms; Esophageal Neoplasms
18
Active, not recruiting
Study of CGC-11047 When Used in Individual Combinations With 1) Gemcitabine or 2) Docetaxel or 3) Bevacizumab or 4) Erlotinib or 5) Cisplatin or 6) 5-Flurouracil or 7) Sunitinib in Patients With Advanced Solid Tumors or Lymphoma
Last Updated: June 13, 2011
Condition(s): Cancer
19
Active, not recruiting
OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer
Last Updated: September 1, 2011
Condition(s): Head and Neck Cancer
20
Recruiting
Trial Comparing the Use of FLT PET to Standard CT to Assess Treatment Response of Neoadjuvant Docetaxel and Cisplatin in Stage IB-IIIA Resectable NSCLC
Last Updated: July 19, 2011
Condition(s): Non Small Cell Lung Cancer

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://www.clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+docetaxel%2C+cisplatin

Page 1 of Clinical Trials for ( Drug docetaxel AND cisplatin ), 288 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About